(PRX) Prosus - Ratings and Ratios
Classifieds, Fintech, Food-Delivery, Edtech, Etail
Description: PRX Prosus September 25, 2025
Prosus N.V. (AS:PRX) is a global internet investment group that builds, scales, and monetises digital platforms across e-commerce, classified ads, fintech, food delivery, education technology, and other online services. Its portfolio spans Asia, Europe, Latin America, North America and other regions, leveraging network effects to capture growth in emerging and mature markets.
Key financial metrics from the most recent fiscal year (FY 2023) show total revenue of €27.9 billion, an adjusted EBITDA margin of roughly 13 %, and a net loss of €1.2 billion driven primarily by a €2.5 billion impairment on its Tencent stake. The company remains the largest single shareholder in Tencent, holding about 27 % of the Chinese tech giant as of Q3 2024, a position that continues to anchor its exposure to the broader Asian digital economy.
Sector-level drivers that underpin Prosus’s growth outlook include the rapid expansion of online payments in Southeast Asia-where e-commerce transaction values are projected to exceed $300 billion by 2026-and the continued scaling of food-delivery platforms, which have seen average order values rise 15 % year-over-year in Latin America. These macro trends provide tailwinds for Prosus’s fintech and delivery assets, while its education-technology segment benefits from increasing government and private spending on digital learning solutions post-pandemic.
For analysts looking to deepen their valuation framework, a quick review of Prosus’s sensitivity to Tencent’s earnings volatility and the performance of its core “Etail” businesses can be a useful starting point; the ValueRay platform offers a granular, data-driven toolkit that may help surface hidden risk-adjusted upside.
PRX Stock Overview
| Market Cap in USD | 154,534m |
| Sub-Industry | Interactive Media & Services |
| IPO / Inception |
PRX Stock Ratings
| Growth Rating | 81.3% |
| Fundamental | 47.8% |
| Dividend Rating | 61.8% |
| Return 12m vs S&P 500 | 27.8% |
| Analyst Rating | - |
PRX Dividends
| Dividend Yield 12m | 0.33% |
| Yield on Cost 5y | 0.50% |
| Annual Growth 5y | 18.92% |
| Payout Consistency | 99.2% |
| Payout Ratio | 16.1% |
PRX Growth Ratios
| Growth Correlation 3m | 87.6% |
| Growth Correlation 12m | 92% |
| Growth Correlation 5y | 20.2% |
| CAGR 5y | 31.66% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.09 |
| CAGR/Mean DD 3y (Pain Ratio) | 2.95 |
| Sharpe Ratio 12m | 1.79 |
| Alpha | 36.79 |
| Beta | 0.688 |
| Volatility | 30.67% |
| Current Volume | 2213.4k |
| Average Volume 20d | 1804.5k |
| Stop Loss | 58.1 (-3.1%) |
| Signal | 0.13 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (14.05b TTM) > 0 and > 6% of Revenue (6% = 479.5m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 2.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 198.3% (prev 316.6%; Δ -118.3pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 1.33b <= Net Income 14.05b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.28b) change vs 12m ago -68.59% (target <= -2.0% for YES) |
| Gross Margin 38.20% (prev 29.82%; Δ 8.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 11.89% (prev 9.25%; Δ 2.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.93 (EBITDA TTM -234.0m / Interest Expense TTM 549.0m) >= 6 (WARN >= 3) |
Altman Z'' 8.83
| (A) 0.22 = (Total Current Assets 22.08b - Total Current Liabilities 6.23b) / Total Assets 72.59b |
| (B) 1.09 = Retained Earnings (Balance) 79.33b / Total Assets 72.59b |
| warn (B) unusual magnitude: 1.09 — check mapping/units |
| (C) -0.01 = EBIT TTM -513.0m / Avg Total Assets 67.20b |
| (D) 3.70 = Book Value of Equity 79.33b / Total Liabilities 21.46b |
| Total Rating: 8.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.83
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 0.45% = 0.22 |
| 3. FCF Margin 9.12% = 2.28 |
| 4. Debt/Equity 0.32 = 2.45 |
| 5. Debt/Ebitda -39.16 = -2.50 |
| 6. ROIC - WACC (= -8.87)% = -11.08 |
| 7. RoE 31.19% = 2.50 |
| 8. Rev. Trend 40.13% = 3.01 |
| 9. EPS Trend 49.10% = 2.45 |
What is the price of PRX shares?
Over the past week, the price has changed by +1.09%, over one month by +0.31%, over three months by +19.68% and over the past year by +55.19%.
Is Prosus a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PRX is around 62.47 EUR . This means that PRX is currently overvalued and has a potential downside of 4.24%.
Is PRX a buy, sell or hold?
What are the forecasts/targets for the PRX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66 | 10.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 69.4 | 15.8% |
PRX Fundamental Data Overview January 01, 1970
Market Cap USD = 154.53b (133.13b EUR * 1.1608 EUR.USD)
P/E Trailing = 13.3964
P/E Forward = 16.1812
P/S = 21.5766
P/B = 3.179
Beta = 0.688
Revenue TTM = 7.99b USD
EBIT TTM = -513.0m USD
EBITDA TTM = -234.0m USD
Long Term Debt = 14.92b USD (from longTermDebt, last quarter)
Short Term Debt = 1.35b USD (from shortLongTermDebt, last quarter)
Debt = 16.27b USD (Calculated: Short Term 1.35b + Long Term 14.92b)
Net Debt = 9.16b USD (from netDebt column, last quarter)
Enterprise Value = 163.70b USD (154.53b + Debt 16.27b - CCE 7.11b)
Interest Coverage Ratio = -0.93 (Ebit TTM -513.0m / Interest Expense TTM 549.0m)
FCF Yield = 0.45% (FCF TTM 729.0m / Enterprise Value 163.70b)
FCF Margin = 9.12% (FCF TTM 729.0m / Revenue TTM 7.99b)
Net Margin = 175.8% (Net Income TTM 14.05b / Revenue TTM 7.99b)
Gross Margin = 38.20% ((Revenue TTM 7.99b - Cost of Revenue TTM 4.94b) / Revenue TTM)
Gross Margin QoQ = 40.85% (prev 40.41%)
Tobins Q-Ratio = 2.26 (Enterprise Value 163.70b / Total Assets 72.59b)
Interest Expense / Debt = 3.37% (Interest Expense 549.0m / Debt 16.27b)
Taxrate = 2.45% (82.0m / 3.35b)
NOPAT = -500.5m (EBIT -513.0m * (1 - 2.45%)) [loss with tax shield]
Current Ratio = 3.54 (Total Current Assets 22.08b / Total Current Liabilities 6.23b)
Debt / Equity = 0.32 (Debt 16.27b / totalStockholderEquity, last quarter 51.05b)
Debt / EBITDA = -39.16 (negative EBITDA) (Net Debt 9.16b / EBITDA -234.0m)
Debt / FCF = 12.57 (Net Debt 9.16b / FCF TTM 729.0m)
Total Stockholder Equity = 45.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.36% (Net Income 14.05b / Total Assets 72.59b)
RoE = 31.19% (Net Income TTM 14.05b / Total Stockholder Equity 45.05b)
RoCE = -0.86% (EBIT -513.0m / Capital Employed (Equity 45.05b + L.T.Debt 14.92b))
RoIC = -0.82% (negative operating profit) (NOPAT -500.5m / Invested Capital 61.20b)
WACC = 8.05% (E(154.53b)/V(170.81b) * Re(8.55%) + D(16.27b)/V(170.81b) * Rd(3.37%) * (1-Tc(0.02)))
Discount Rate = 8.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -28.69%
[DCF Debug] Terminal Value 72.14% ; FCFE base≈729.0m ; Y1≈572.2m ; Y5≈374.0m
Fair Price DCF = 2.85 (DCF Value 6.38b / Shares Outstanding 2.24b; 5y FCF grow -25.66% → 3.0% )
EPS Correlation: 49.10 | EPS CAGR: 731.0% | SUE: N/A | # QB: 0
Revenue Correlation: 40.13 | Revenue CAGR: 39.50% | SUE: -0.05 | # QB: 0